HELIOS TECHNOLOGIES, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data HELIOS TECHNOLOGIES, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2026
Revenue	197	343	508	555	523	869	885	836	806	839
Cost of revenue	126	206	315	342	327	556	587	574	554	568
Gross profit	71.3	137	193	212	196	313	299	262	252	271
Research and development	4.33	10.6	14.1	15.2	15.6	16.8	17.4	19.2	20.1	19.1
Selling, general and administrative	35.3	65.6	93.9	99.7	107	131	133	149	139	148
Operating income	34.5	61.5	75.6	90.1	35.4	149	137	79.9	81.8	66
Interest expense	0.48	4.08
Other non-operating income	-0.74	-0.74	-0.24	-0.27	0.3	-0.2	0.3	1.1	3.8	19.6
Pre-tax income	34.9	47.5	56.4	75.3	24	131	122	49.2	50.5	62.4
Income tax	11.6	16	9.67	15	9.8	26.6	23.4	11.7	11.5	14
Net income	23.3	31.6	46.7	60.3	14.2	105	98.4	37.5	39	48.4
EBITDA	45.8	80.7	115	125	75.1	204	189	144	146	129
EPS, basic	0.87	1.17	1.49	1.88	0.44	3.24	3.03	1.14	1.17	1.46
EPS, diluted	0.87	1.17	1.49	1.88	0.44	3.22	3.02	1.14	1.17	1.45
Shares, basic (weighted)	26.9	27	31.3	32	32.1	32.3	32.5	32.9	33.2	33.2
Shares, diluted (weighted)	26.9	27	31.3	32.1	32.2	32.5	32.6	33	33.3	33.3
Dividend per share	0.40	0.38	0.36	0.36	0.36	0.36	0.36	0.36	0.36	0.36

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2026
Cash and equivalents	74.2	63.9	23.5	22.1	25.2	28.5	43.7	32.4	44.1	73
Receivables	25.7	37.5	72.8	66.7	97.6	135	125	115	105	116
Inventory	30	41.5	86	85.2	110	166	192	215	190	189
Other current assets	3.94	3.81	10	15.4	19.7	20.1	17.9	23.1	30.3	21.9
Total current assets	141	147	197	193	254	352	389	397	384	415
Property, plant and equipment	80.5	91.9	127	134	147	151	157	202	194	189
Lease right-of-use assets				12.3	16.6	22.8	19.2	25.8	22.9	17.6
Goodwill	104	109	383	378	444	460	469	514	499	498
Intangible assets	113	104	321	295	419	413	406	426	384	370
Other non-current assets	3.14	3.41	5.3	5.29	10.2	13.9	23.8	23.7	19.8	23.1
Total assets	445	460	1,042	1,022	1,297	1,415	1,464	1,590	1,505	1,515
Accounts payable	10.2	15.5	40.9	29.7	59.5	85.3	73.7	70.3	56.7	75.6
Accrued liabilities	7.46	5.05	9.94	16.9	23	28.6	21.1	19.4	24.6	23.3
Deferred revenue			0.14	0.35	4.21	4.4	3.3	2.1	2.7	0.4
Short-term debt			5.22	7.62	16.2	18.1	19	23.2	16	5.4
Total current liabilities	31.1	45.9	93	76.5	128	170	152	145	139	143
Long-term debt			91.7	84.1	190	184	164	298	283	256
Lease liabilities				9.31	12.7	17.9	14.5	23.2	20.3	15.3
Other non-current liabilities	3.49	6.38	12.3	25.6	36.5	38.7	30	35.7	30.8	25.7
Total liabilities	208	187	511	444	689	706	669	736	641	583
Total debt			354	301	463	446	447	525	451	368
Paid-in capital	89.7	95.4	358	365	372	395	404	434	437	443
Retained earnings	162	184	219	268	270	363	450	476	503	539
Treasury stock									0	-13.6
Other comprehensive income	-15.8	-6.48	-46.3	-55.4	-34.3	-49	-59.4	-55.4	-75.6	-36.9
Shareholders' equity	236	273	531	578	608	709	795	855	864	932
Total equity	236	273	531	578	608	709	795	855	864	932
Total liabilities and equity	445	460	1,042	1,022	1,297	1,415	1,464	1,590	1,505	1,515
Shares outstanding	26.9	27.1	32	32	32.1	32.4	32.6	33.1	33.3	33.1

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2026
Net income	23.3	31.6	46.7	60.3	14.2	105	98.4	37.5	39	48.4
Depreciation and amortization	11.3	19.2	39.7	35.2	39.7	54.4	51.6	63.8	63.8	63
Stock-based compensation	4.85	4.04	4.27	5.21	5.8	8.9	8.6	11.6	3.4	5.1
Deferred income tax	-0.44	-6.77	-0.79	-1.06	-2	-4.5	-5.2	-7.9	-8.6	-0.8
Change in receivables	-3.16	-11.1	-5.98	5.66	0.7	-32.4	9.1	16.3	7.3	-16.5
Change in inventory	-1.38	-13.1	-11.7	-1.45	0.6	-52.5	-27	-17.9	19.4	-2.7
Change in payables	2.57	5.78	5.89	-10.8	10.6	23.8	-11.5	-5.2	-11.8	22
Cash from operations	38.5	49.4	77.5	90.5	109	113	110	83.9	122	127
Capital expenditures	-6.19	-22.2	-28.4	-25	-14.6	-26.8	-31.9	-34.3	-27	-23.7
Acquisitions	-200	-0.5	-535		-217	-61.1	-67.3	-114	0	0
Purchases of investments	-24.7
Cash from investing	-170	-16	-566	-22.4	-236	-90.3	-90.8	-154	-30.3	20.3
Debt issued			101		120	12	0	160	127	0
Debt repaid			-3.83	-5.47	-6	-16.2	-18	-21.5	-148	-38.2
Stock issued	1.04	1.16	241	1.65	1.3	1.8	2.1	2	2.2	1.8
Dividends paid	-10.7	-10.3	-11	-11.5	-11.6	-11.6	-11.7	-11.8	-11.9	-12
Cash from financing	128	-50.1	447	-71.7	138	-22.6	-6.9	57.9	-78.4	-122
Exchange rate effect	-4.66	6.35	0.32	2.26	-7.3	3	3	0.8	-1.7	3.2
Net change in cash	-7.72	-10.3	-40.4	-1.35	3.1	3.2	15.2	-11.3	11.7	28.9
Free cash flow	32.3	27.2	49.1	65.5	94	86.3	78	49.6	95.1	104
Interest paid	0.36	3.72	12.8	14.3	11.6	15.9	15.5	29.5	32.4	29.8
Income taxes paid	12.8	17.5	20.2	11.4	11.3	23.6	31.7	26.4	21.1	16.1

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 4, 2026; growth uses fiscal years. Valuation uses the share price of $68.64 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	33.5%	Gross profit / revenue.
Operating margin	10.0%	Operating income / revenue.
EBITDA margin	16.9%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	10.3%	Pre-tax income / revenue.
Net margin	8.0%	Net income / revenue.
FCF margin	12.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	15.4%	Cash from operations / revenue.
Effective tax rate	22.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	7.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	4.7%	Net income / average total assets.
Return on invested capital (ROIC)	5.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	17.2%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.7%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	3.4%	Capital expenditures / revenue.
D&A / revenue	6.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	4.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-1.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	9.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	7.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-3.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	6.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-19.3%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-21.7%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	13.3%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-11.4%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-11.9%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	11.4%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	24.1%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-21.1%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	27.8%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	23.9%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-21.7%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	26.9%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	4.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	5.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	3.2%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	8.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	9.9%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	2.0%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	0.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	7.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	5.4%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	8.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	0.6%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	1.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	3.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.7%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.74x	Current assets / current liabilities.
Quick ratio	1.30x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.43x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.35x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	21.9%	Total debt / total assets.
Liabilities / assets	37.4%	Total liabilities / total assets.
Net debt	$264.3M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	1.75x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$278.8M	Current assets - current liabilities.
Goodwill and intangibles / assets	55.5%	(Goodwill + intangible assets) / total assets.
Tangible book value	$106.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.59x	Revenue / average total assets.
Inventory turnover	3.05x	Cost of revenue / average inventory.
Days inventory	120 days	365 x average inventory / cost of revenue.
Receivables turnover	6.34x	Revenue / average receivables.
Days sales outstanding	58 days	365 x average receivables / revenue.
Days payables	54 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	123 days	Days inventory + days sales outstanding - days payables.
FCF conversion	149.9%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	22.0%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.15	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$26.85	Revenue / diluted weighted shares.
FCF per share	$3.22	Free cash flow / diluted weighted shares.
Operating cash flow per share	$4.13	Cash from operations / diluted weighted shares.
Book value per share	$28.74	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$3.23	Tangible book value / shares outstanding.
Cash per share	$2.06	(Cash + short-term investments) / shares outstanding.
Payout ratio	18.1%	Dividends paid / net income, when net income is positive.
Dividends / FCF	12.1%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$2.26B	Share price x shares outstanding.
Enterprise value	$2.53B	Market cap + total debt - cash - short-term investments.
P/E	31.7x	Market cap / net income. Only when net income is positive.
P/S	2.54x	Market cap / revenue.
P/B	2.39x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	21.2x	Market cap / tangible book value, when positive.
P/FCF	21.2x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	16.5x	Market cap / cash from operations, when positive.
EV/Sales	2.83x	Enterprise value / revenue.
EV/EBIT	28.2x	Enterprise value / operating income, when both are positive.
EV/EBITDA	16.7x	Enterprise value / EBITDA, when both are positive.
EV/FCF	23.6x	Enterprise value / free cash flow, when both are positive.
FCF yield	4.7%	Free cash flow / market cap.
Earnings yield	3.2%	Net income / market cap (the inverse of P/E).
Dividend yield	0.6%	Dividends paid over the period / market cap.
Shareholder yield	0.6%	(Dividends paid + share buybacks) / market cap.

What was HELIOS TECHNOLOGIES, INC.'s revenue in fiscal 2026?

HELIOS TECHNOLOGIES, INC. reported revenue of $839.0M for fiscal 2026, 4.1% higher than the year before.

Was HELIOS TECHNOLOGIES, INC. profitable in fiscal 2026?

Yes. Net income was $48.4M, a net margin of 5.8%.

How much free cash flow did HELIOS TECHNOLOGIES, INC. generate in fiscal 2026?

Cash from operations of $127.3M minus capital expenditures of $23.7M left free cash flow of $103.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to HELIOS TECHNOLOGIES, INC.